Page last updated: 2024-10-28
miltefosine and Immune System Diseases
miltefosine has been researched along with Immune System Diseases in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Immune System Diseases: Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Oral treatment with miltefosine is generally well tolerated and has relatively few adverse effects." | 1.40 | Repurposing miltefosine for the treatment of immune-mediated disease? ( Hommes, DW; Peppelenbosch, MP; van den Brink, GR; Verhaar, AP; Wildenberg, ME, 2014) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Verhaar, AP | 1 |
Wildenberg, ME | 1 |
Peppelenbosch, MP | 1 |
Hommes, DW | 1 |
van den Brink, GR | 1 |
Other Studies
1 other study available for miltefosine and Immune System Diseases
Article | Year |
---|---|
Repurposing miltefosine for the treatment of immune-mediated disease?
Topics: Adaptive Immunity; Adjuvants, Immunologic; Drug Discovery; Humans; Immune System Diseases; Immunity, | 2014 |